Product Information
JUNEL 1 MG-20 MCG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1812 per EA under NDC 00555902542. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 30, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20; 1 ug/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555902542
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; NORETHINDRONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA076380FDA Approved
5/30/2003
TE Code
AB
On Market Since
9/18/2003
Price Statistics
The NADAC for JUNEL 1 MG-20 MCG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 78.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1812 per EA |
|---|---|
| All-time high | $0.9257 (Apr 16, 2014) |
| All-time low | $0.1619 (Nov 20, 2024) |
| 52-week high | $0.1842 |
| 52-week low | $0.1652 |
| Median price | $0.3575 |
| Average price | $0.4327 |
| Largest weekly change | +37.1% (May 22, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norethindrone Acetate and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of JUNEL 1 MG-20 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for JUNEL 1 MG-20 MCG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1812 per EA (NDC 00555902542), effective Sep 30, 2026.
How has the price of JUNEL 1 MG-20 MCG TABLET changed over time?
Over the history we have for it, the NADAC for JUNEL 1 MG-20 MCG TABLET has declined 78.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for JUNEL 1 MG-20 MCG TABLET?
Since Nov 28, 2013, the NADAC for JUNEL 1 MG-20 MCG TABLET has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.9257 (Apr 16, 2014), with a median of $0.3575 per EA.
Are there cheaper alternatives to JUNEL 1 MG-20 MCG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as JUNEL 1 MG-20 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures JUNEL 1 MG-20 MCG TABLET?
JUNEL 1 MG-20 MCG TABLET (NDC 00555902542) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.